Grow your business safely with EUROFINS DEV BIOPHARMA FRANCE 3

All the information you need about EUROFINS DEV BIOPHARMA FRANCE 3 to develop and secure your business in France

E HOME > CORPORATES > EUROFINS DEV BIOPHARMA FRANCE 3 > BALANCE SHEET ( 2019-05-22)

THE LIST OF BALANCE SHEET : EUROFINS DEV BIOPHARMA FRANCE 3

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2022-06-22 Public 2021-12-31 Complete
2021-06-22 Public 2020-12-31 Complete
2020-11-25 Public 2019-12-31 Complete
2019-05-22 Public 2018-12-31 Complete
2018-06-11 Public 2017-12-31 Complete
NameEUROFINS PRODUCT TESTING 2 FRANCE HOLDING
Siren833456783
Closing2018-12-31
Registry code 4401
Registration number 6689
Management number2017B03194
Activity code 7120B
Closing date n-11901-01-01
Duration Fiscal year 00
Duration Fiscal year n-100
Filing date2019-05-22
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address44300 NANTES
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
BJ TOTAL (I) 11 967 094.00 11 967 094.00 11 967 094.00
BZ Other receivables 30 705.00 30 705.00 30 705.00
CF Cash and cash equivalents 298 400.00 298 400.00 298 400.00
CJ TOTAL (II) 329 105.00 329 105.00 329 105.00
CO Grand total (0 to V) 12 296 199.00 12 296 199.00 12 296 199.00
CU Other investments 11 967 094.00 11 967 094.00 11 967 094.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 5 205 000.00 5 000.00 5 205 000.00
DH Retained earnings -1 300.00 -1 300.00
DI RESULTS FOR THE YEAR (Profit or Loss) -69 744.00 -1 300.00 -69 744.00
DL TOTAL (I) 5 133 956.00 3 700.00 5 133 956.00
DX Trade payables and related accounts 1 610.00 1 300.00 1 610.00
EA Other liabilities 7 160 633.00 7 160 633.00
EC TOTAL (IV) 7 162 243.00 1 300.00 7 162 243.00
EE Grand total (I to V) 12 296 199.00 5 000.00 12 296 199.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
FW Other purchases and external expenses 10 888.00
FX Taxes, duties, and similar payments 12 467.00
GF Total Operating Expenses (II) 23 355.00
GG - OPERATING RESULT (I - II) -23 355.00
GR Interest and similar expenses 46 389.00
GU Total financial expenses (VI) 46 389.00
GV - FINANCIAL INCOME (V - VI) -46 389.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) -69 744.00
4 - Income statement (continued)Amount year NAmount year N-1
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 69 744.00 1 300.00 69 744.00
HN PROFIT OR LOSS (Total revenue - Total expenses) -69 744.00 -1 300.00 -69 744.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 11 967 094.00 11 967 094.00
I3 DECREASES Total Financial Fixed Assets 11 967 094.00
I4 DECREASES Grand Total 11 967 094.00
LQ ACQUISITIONS Total Financial Fixed Assets 11 967 094.00 11 967 094.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8B Suppliers and Related Accounts 1 610.00 1 610.00 1 610.00
VB VAT 246.00 246.00 246.00
VI Group and Associates 7 160 633.00 46 389.00 7 114 244.00 7 160 633.00
VR Miscellaneous debtors (including receivables related to repo transactions) 30 459.00 30 459.00 30 459.00
VY TOTAL – STATEMENT OF LIABILITIES 7 162 243.00 47 999.00 7 114 244.00 7 162 243.00

all companies in France

Complete and comprehensive database.